Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

TD Securities Upgrades Range Resources to Buy, Raises Price Target to $33

TD Securities analyst Aaron Bilkoski upgrades Range Resources (NYSE:RRC) from Hold to Buy and raises the price target from $32 to $33.
byBenzinga Newsdesk
September 29, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

TD Securities analyst Aaron Bilkoski upgrades Range Resources (NYSE:RRC) from Hold to Buy and raises the price target from $32 to $33.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Ipsen Announced Onivyde Regimen Demonstrated Statistically Significant Improvement in Overall Survival in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma; Trial Met its Primary Endpoint and Key Secondary Endpoint

By Charles Gross
November 9, 6:21 AM
Ipsen (Euronext: IPN; ADR: IPSEY) announced the Phase III NAPOLI 3 trial of Onivyde® (irinotecan liposome injection) plus 5 fluorouracil/leucovorin and oxaliplatin (NALIRIFOX regimen) met its primary endpoint demonstrating clinically meaningful and statistically significant improvement in overall survival compared to nab-paclitaxel plus gemcitabine in 770 previously untreated patients with metasta

IPSEY